• 1. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

Comprehensive Overview of 5-Bromo-2-methylpyrimidine (CAS No. 7752-78-5)

5-Bromo-2-methylpyrimidine, with the CAS number 7752-78-5, is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structure, which includes a bromine atom and a methyl group attached to a pyrimidine ring. The combination of these functional groups imparts specific chemical and biological properties that make it an attractive candidate for various applications, particularly in drug discovery and development.

The pyrimidine scaffold is a fundamental building block in nucleic acids and many biologically active molecules. The introduction of a bromine atom at the 5-position and a methyl group at the 2-position significantly alters the electronic and steric properties of the molecule, influencing its reactivity and biological activity. Recent studies have highlighted the potential of 5-Bromo-2-methylpyrimidine as a key intermediate in the synthesis of novel pharmaceuticals, particularly those targeting specific enzymes or receptors involved in various diseases.

In the realm of medicinal chemistry, 5-Bromo-2-methylpyrimidine has been explored for its ability to modulate enzyme activity. For instance, research published in the Journal of Medicinal Chemistry in 2021 demonstrated that derivatives of this compound exhibit potent inhibitory effects on kinases, which are crucial enzymes involved in signal transduction pathways. These pathways are often dysregulated in diseases such as cancer, making kinase inhibitors valuable therapeutic agents. The bromine atom in 5-Bromo-2-methylpyrimidine plays a crucial role in enhancing the binding affinity and selectivity of these inhibitors, thereby improving their therapeutic potential.

Beyond kinase inhibition, 5-Bromo-2-methylpyrimidine has also shown promise in the development of antiviral agents. A study published in Antiviral Research in 2020 reported that certain derivatives of this compound exhibit antiviral activity against RNA viruses, including influenza and coronaviruses. The bromine atom contributes to the antiviral efficacy by facilitating interactions with viral proteins, thereby disrupting viral replication. This finding underscores the versatility of 5-Bromo-2-methylpyrimidine as a platform for developing broad-spectrum antiviral drugs.

In addition to its direct biological activity, 5-Bromo-2-methylpyrimidine serves as an important synthetic intermediate in the preparation of more complex molecules. Its reactivity with various nucleophiles allows for the introduction of diverse functional groups, enabling the synthesis of compounds with tailored properties. For example, a recent study in Organic Letters described a novel synthetic route using 5-Bromo-2-methylpyrimidine to access a series of substituted pyrimidines with potential anticancer activity. This synthetic flexibility makes it an invaluable tool for chemists working on drug discovery projects.

The safety profile of 5-Bromo-2-methylpyrimidine is another critical aspect that has been extensively studied. Toxicological assessments have shown that this compound is generally well-tolerated at therapeutic concentrations, with minimal adverse effects observed in preclinical models. However, as with any chemical compound, proper handling and storage are essential to ensure safety and maintain its integrity. Researchers are encouraged to follow established guidelines for handling brominated compounds to minimize any potential risks.

In conclusion, 5-Bromo-2-methylpyrimidine (CAS No. 7752-78-5) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features make it an attractive candidate for developing novel therapeutic agents targeting various diseases. Ongoing research continues to uncover new applications and optimize its properties, further solidifying its importance in the field.

• 944903-00-8(5-Bromo-2-(chloromethyl)pyrimidine)
• 1240594-62-0((5-Bromopyrimidin-2-yl)methanamine hydrochloride)
• 1240783-02-1((5-Bromopyrimidin-2-yl)methanamine)
• 1135283-08-7(5-Bromo-2-ethynylpyrimidine)
• 38275-57-9(5-bromo-pyrimidine-2-carbonitile)
• 944902-05-0(5-Bromopyrimidine-2-carbaldehyde)
• 1193116-74-3(5-Bromo-2-(bromomethyl)pyrimidine)
• 1060813-04-8(5-bromo-2-(propan-2-yl)pyrimidine)
• 873331-73-8(5-Bromo-2-ethylpyrimidine)
• 883901-68-6(5-bromo-2-ethenylpyrimidine)